References
- Knill-Jones R P. Geographical differences in the prevalence of dyspepsia. Scand J Gastroenterol 1991; 26: 17–24, Suppl 182
- Talley N J. Spectrum of chronic dyspepsia in the presence of the irritable bowel syndrome. Scand J Gastroenterol 1991; 26: 7–10, Suppl 182
- Malagelada J R., Stanghellini V. Manometric evaluation of functional upper gut symptoms. Gastroenterology 1985; 88: 1223–31
- Nyren O. Secretory abnormalities in dyspepsia. Scand J Gastroenterol 1991; 26: 25–8, Suppl 182
- Talley N J. Drug treatment of functional dyspepsia. Scand J Gastroenterol 1991; 26: 47–60, Suppl 182
- Schuurkes J AJ, Helsen L FM, Ghoos E, et al. Stimulation of gastroduodenal motor activity: dopaminergic and cholinergic modulation. Drug Dev Res 1985; 8: 233–41
- Meulemans A L., Schuurkes J AJ. Is the action of cisapride on the guinea-pig ileum mediated via 5-HT4 receptors?. Eur J Pharmacol 1992; 212: 51–9
- Chen H T., Wiley J, Owyang C. Mechanism of action of cisapride: evidence of regional difference in the gastrointestinal tract [abstract]. Gastroenterology 1986; 90: 1370
- Reyntjens A, Verlinden M, De Coster R, et al. Clinical pharmacological evidence for cisapride's lack of direct cholinergic properties. CurrTherRes 1984; 36: 1045–52
- Corinaldesi R, Raiti C, Stanghellini V, et al. Comparative effects of oral cisapride and metoclopramide on gastric emptying of solids and symptoms in patients with functional dyspepsia and gastroparesis. Curr Ther Res 1987; 42: 428–35
- Manousos O N., Apostolos M, Michailidis D. Treatment of reflux symptoms in oesophagitis patients: comparative trial of cisapride and metoclopramide. Curr Ther Res 1987; 42: 807–13
- Ghigliani M, Iantorno G, Vazquez S, et al. Acute effects of gastrokinetics–cisapride and metoclopramide–on the gastric emptying function in patients with the early satiety syndrome. Acta Gastroenterol Latinam 1987; 17: 43–56
- Mc Hugh S, Lico S, Diamant N E. Cisapride vs metoclopramide. An acute study in diabetic gastroparesis. Dig Dis Sci 1992; 37: 997–1001
- Chouinard G, Ross-Chouinard A, Lawrence B D., et al. Extrapyramidal symptom rating scale. Can J Neur Sci 1980; 7: 233
- Rösch W. Das neue Gastroprokinetikum Cisaprid (3×5 mg). Wie wirksam beim Reizmagen-Syndrom? Offene multizen-trische Therapiestudie uber 2 bis 4 Wochen. Therapiewoche 1991; 41: 1868–72
- Koelz H R., Schweizer-Studiengruppe N UD. Randomisierte Doppelblind-Studien zur Behandlung der nicht ulzerosen Dys-pepsie mit Cisaprid und Ranitidin. 54th Meeting of the Swiss Society of Gastroenterology, Sion, September, 1989
- Heyse P M., Rambaldo R, Hazelhoff B. Factors affecting short -and long-term outcome of a short therapeutic trial with cisapride in dyspeptic patients. Scand J Gastroenterol 1993; 28: 15–24, Suppl 195
- Heading R C. Definitions of dyspepsia. Scand J Gastroenterol 1991; 26: 1–6, Suppl 182
- Champion M C., Gulenchyn K, Braaten J, et al. Cisapride (Pre-pulsid) is effective in the management of diabetic gastroparesis [abstract]. J Gastroenterol Hepatol 1990; 5S: 25
- Horowitz M, Maddox A, Harding P E., et al. The effect of single dose and chronic administration of cisapride on gastric and oesophageal emptying in insulin-dependent diabetes mellitus. Gastroenterology 1987; 92: 1899–907
- Shade R R., Dugas M C., Lhotsky D M., et al. Effect of metoclopramide on gastric liquid emptying in patients with diabetic gastroparesis. Dig Dis Sci 1985; 30: 10–5
- Waldron B, Cullen P T., Kumar R, et al. Evidence for hypo-motility in non-ulcer dyspepsia: a prospective multifactorial study. Gut 1991; 32: 246–51